awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50089384-BDFBF6CD-562D-4396-8046-07047D913326
Q50089384-BDFBF6CD-562D-4396-8046-07047D913326
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50089384-BDFBF6CD-562D-4396-8046-07047D913326
Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis.
P2860
Q50089384-BDFBF6CD-562D-4396-8046-07047D913326
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50089384-BDFBF6CD-562D-4396-8046-07047D913326
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d569d3f39401c17009d155acca47707bfd2e086d
P2860
U.S. FDA Approval Summary: Nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab.